Skip to main content

Table 2 Anthropometrical evaluation and serum C-reactive protein levels in human immunodeficiency virus (HIV)-infected and HIV-uninfected children being treated for tuberculosis on enrolment after 1 month and 4 months of treatment.

From: Rifampin pharmacokinetics in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis

 

Human immunodeficiency virus-infected

N= 21 (SD)

Human immunodeficiency virus-

uninfected

N= 33

(SD)

Pvalue

Human immunodeficiency virus-infected

N= 21

(SD)

Human immunodeficiency virus-uninfected

N= 33

(SD)

Pvalue

 

On enrolment

  

After 4 months of

treatment

  

Weight (kg)

12.26

(5.18)

13.97

(6.94)

0.30

13.06

(5.33)

15.04

(8.01)

0.29

Length/height (cm)

86.80

(16.22)

91.53

(20.85)

0.36

89.26

(16.39)

93.67

(20.37)

0.40

Body mass index

15.59

(1.62)

15.71

(1.91)

0.80

15.74

(1.53)

16.05

(1.71)

0.51

Mid-upper arm circumference (cm)

14.28

(2.16)

15.07

(2.39)

0.21

14.44

(2.22)

15.46

(2.63)

0.16

Serum C-reactive protein

(mg/litre)

39.97

(54.55)

13.42

(17.96)

0.06

22.47

(22.28)

4.15

(4.96)

0.002

  1. SD, standard deviation.